Use of urticae polysaccharide in preparation of anti-hyperuricemia drugs

By extracting and purifying nettle polysaccharides from nettle plants, an anti-hyperuricemia drug was prepared, which solved the problem of adverse reactions of existing chemical drugs and achieved a highly effective and low-toxicity uric acid-lowering effect and kidney protection.

CN122398846APending Publication Date: 2026-07-17DALIAN UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
DALIAN UNIV
Filing Date
2026-04-15
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

Existing chemical drugs used to treat hyperuricemia have adverse reactions, and research on the uric acid-lowering effect of nettle polysaccharide has not been fully explored.

Method used

Nettle polysaccharides were extracted from the aerial parts of nettle plants and purified using steps such as water extraction, alcohol precipitation, protein removal, and ultrafiltration to prepare a pharmaceutically acceptable dosage form for the prevention and treatment of hyperuricemia.

Benefits of technology

Nettle polysaccharides significantly reduce serum uric acid levels, protect kidney function, and are highly effective, low in toxicity, inexpensive, and easy to produce industrially.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
Patent Text Reader

Abstract

本发明属于药物制备技术领域，公开了荨麻多糖在制备抗高尿酸血症药物的应用。本发明首次发现并证实了荨麻多糖具有显著的抗高尿酸血症活性，开拓了荨麻多糖的全新医药用途，为该天然产物的高附加值开发提供了新方向，并且荨麻多糖原料易得，制备工艺成熟：荨麻资源丰富，多糖的提取纯化工艺简单、成本低廉，易于实现工业化生产。
Need to check novelty before this filing date? Find Prior Art